Recursion Pharmaceuticals (RXRX) Shares Outstanding (Diluted) (2020 - 2026)
Recursion Pharmaceuticals' Shares Outstanding (Diluted) came in at 532.46 million for Q2 2026, up 27.6% from 417.36 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Recursion Pharmaceuticals' Shares Outstanding (Diluted) was 447.45 million, up 63.2% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last six years, with a five-year compound annual growth rate of 83.0% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 274.21 million in FY2024 (+31.9%), 207.85 million in FY2023 (+18.4%), 175.54 million in FY2022 (+40.0%) and 125.35 million in FY2021 (+475.5%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2020.
- Year-over-year, Shares Outstanding (Diluted) has increased for 22 consecutive quarters, with growth averaging 48.4% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 2.9% in Q3 2022 to 672.5% in Q3 2021.
- Business Quant data shows RXRX's Shares Outstanding (Diluted) at 529.3 million (Q1 2026), 447.45 million (Q4 2025) and 446.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn | 532.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 532.46 Mn |
| Mar 31, 2026 | 529.30 Mn |
| Dec 31, 2025 | 447.45 Mn |
| Sep 30, 2025 | 446.99 Mn |
| Jun 30, 2025 | 417.36 Mn |
| Mar 31, 2025 | 402.77 Mn |
| Dec 31, 2024 | 274.21 Mn |
| Sep 30, 2024 | 282.58 Mn |
| Jun 30, 2024 | 242.20 Mn |
| Mar 31, 2024 | 236.02 Mn |
| Dec 31, 2023 | 207.85 Mn |
| Sep 30, 2023 | 214.33 Mn |
| Jun 30, 2023 | 201.42 Mn |
| Mar 31, 2023 | 191.62 Mn |
| Dec 31, 2022 | 175.54 Mn |
| Sep 30, 2022 | 173.44 Mn |
| Jun 30, 2022 | 172.21 Mn |
| Mar 31, 2022 | 170.69 Mn |
| Dec 31, 2021 | 125.35 Mn |
| Sep 30, 2021 | 168.53 Mn |
API Access
Recursion Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();